Rosuvastatin Tablet, Coated
Product Images NDC 11788-130

Each coated tablet contains 10 mg of rosuvastatin (equivalent to 10.4 mg of Rosuvastatin Calcium). The usual dosage and additional prescribing information can be found in the package insert. Store between 20°C to 25°C (68°F to 77°F), with excursions permitted to 15°C to 30°C (59°F to 86°F). Ensure the medication is stored in a tight container as per USP guidelines. Keep this medication and all drugs out of the reach of children. For more information, visit https://aipingpharmaceutical.com/products. This medication is manufactured for Pharmoceeial in Hauppauge, NY with a total of 1000 Tablets. [REGE Rev:10/2025]. Note: Print Patient Information from the provided website.*

This text provides information about a medication containing Rosuvastatin, a type of drug used to lower cholesterol levels. The text includes details such as the dosage, storage instructions, manufacturer (AiPing Pharmaceutical, Inc.), and a reminder to keep all drugs out of the reach of children. It also mentions a website for printing patient information and indicates that the tablets come in child-resistant closures.*

Each coated tablet contains 10 mg of rosuvastatin (equivalent to 10.43 mg of Rosuvastatin Calcium). The usual dosage should be checked in the package insert for full prescribing information. Store the tablets at 20°C to 25°C (68°F to 77°F) and it can be briefly exposed to temperatures of 15°C to 30°C (59°F to 86°F). Protect the medication from moisture and dispense it in a tight container as per the USP standards, ensuring it is child-resistant. For more information, visit the website listed and note that the product is manufactured by APing Pharmaceutical, Inc. in Hauppauge, NY.*

The text mentions a drug with NDC code 11788-132-10, containing 20 mg of rosuvastatin calcium. It also provides instructions for storage, dosage, and dispensing. The drug should be stored between 20°C to 25°C and protected from moisture. The drug is manufactured by AiPing Pharmaceutical, Inc. and there is information for patients available at their website. It is recommended to keep this drug and all medications out of the reach of children.*

This is a description of a medication containing rosuvastatin, represented by NDC 11788-132-05. Each coated tablet contains 20 g of rosuvastatin (equivalent to 20.8 mg of Rosuvastatin Calcium). The usual dosage instructions can be found in the package insert. It is recommended to store the tablets at 20°C to 25°C, with excursions permitted between 15°C to 30°C. It is crucial to protect the medication from moisture and dispense it in a tight container with a child-resistant closure. The medication should be kept out of the reach of children. For more information, patient information can be found at aipingpharmaceutical.com/products. The medication is manufactured for AiPing Pharmaceutical, Inc. located in Hauppauge, NY.*

The text provides information about Rosuvastatin Calcium tablets. It indicates the usual dosage, storage instructions, and manufacturer details for the product. The tablets contain 20 mg of rosuvastatin and come in a child-resistant packaging. For more patient information, visit the website provided.*

The text provides information about a medication containing 40 mg of rosuvastatin, equivalent to 41.6 mg of Rosuvastatin Calcium per coated tablet. It also includes storage instructions (20°C to 25°C) and details for dispensing in a tight container with a child-resistant closure. The manufacturer is AiPing Pharmaceutical, Inc., located in Hauppauge, NY 11788. The text advises keeping the medication away from moisture and out of the reach of children. For full prescribing information, it is recommended to refer to the package insert. Additionally, the patient information can be accessed at https://aipingpharmaceutical.com/products.*

This text provides information about rosuvastatin tablets containing 40 mg of rosuvastatin. It includes instructions on dosage, storage conditions, and safety precautions. It also mentions the manufacturer, AiPing Pharmaceutical, Inc., located in Hauppauge, NY. The NDC code is 11788-133-05. For full prescribing information, it advises referring to the package insert. The pharmaceutical company's website is provided for patient information. Please visit https:/aipingpharmaceutical.com/products.*

This text provides information about a medication in the form of coated tablets containing 40 mg of rosuvastatin (equivalent to 41.6 mg of Rosuvastatin Calcium). It includes storage instructions, dosage details, and mentions the manufacturer as AlPing Pharmaceutical, Inc. The medication is prescribed for certain medical conditions, and caution is advised to keep it out of the reach of children. For more comprehensive prescribing information, one can refer to the package insert.*

This is information about Rosuvastatin tablets containing 5mg of active ingredient per coated tablet. The usual dosage and storage instructions are provided, as well as caution to keep it away from children. Additional details include a web address for patient information and manufacturing details for Aiping Pharmaceutical, Inc.*

This is a description of Rosuvastatin 5mg tablets. Each coated tablet contains 5 mg of rosuvastatin and is equivalent to 5.2 mg of Rosuvastatin Calcium. It is a prescription medication meant for adult use. The usual dosage instructions can be found in the package insert. The tablets should be stored at 20°C to 25°C (68°F to 77°F) with excursions permitted to 15°C to 30°C (59°F to 86°F). The drug should be protected from moisture and dispensed in a tight container with a child-resistant closure as per USP regulations. The manufacturer is Aipin Pharmaceutical, Inc. located in Hauppauge, NY 11788. It is important to keep this drug and all medications out of the reach of children. For more information, visit https://aipingpharmaceutical.com/products.*

This text is a pharmaceutical label providing information on Rosuvastatin Calcium tablets. It includes details on dosage, storage conditions, and safety measures. It mentions the manufacturer as APing Pharmaceutical, Inc. based in Hauppauge, NY. The tablets contain 5 mg of Rosuvastatin. The text also includes a web link for patient information and a reference number for the product.*

This is a description of Figure 1 from the JUPITER study showing the time to the first occurrence of major cardiovascular events. The graph includes data points for different years, number at risk for RSV and Placebo groups, and hazard ratios with 95% confidence intervals. These data points are crucial for assessing the impact of the intervention on major cardiovascular events over time.*

This text provides data on major cardiovascular events in the JUPITER study, comparing the treatment group with Rosuvastatin 20 mg to a placebo group. It includes the hazard ratios, number of events, and event rates for various endpoints such as cardiovascular death, nonfatal stroke, nonfatal MI (myocardial infarction), hospitalized unstable angina, and arterial revascularization. The results suggest that treatment with Rosuvastatin 20 mg was associated with a lower risk of these cardiovascular events compared to placebo.*

Description: The text presents a figure showing the percent change in LDL-C levels at week 6 in adult patients with hyperlipidemia or mixed dyslipidemia based on different doses of rosuvastatin, atorvastatin, simvastatin, and pravastatin. The doses range from 10mg to 80mg for each statin, with data on baseline levels and percentage change provided for comparison. This information can be valuable for understanding the efficacy of different statins in managing lipid levels in patients.*